INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
PE

Pershing Edward

Director, CEOCIK 0001689739

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score9
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
PE
Pershing EdwardDirector, CEO, 10% Owner
PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
Option exercise
M—Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    PROVECTUS BIOPHARMACEUTICALS, INC.Director, CEO · Nov 28, 2025
9
PE
Pershing EdwardDirector, CEO, 10% Owner
PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
Option exercise
M
—
7,599 sh
Oct 23, 2026
Oct 23, 2026
traded Oct 23, 2026
+0d
SEC FORM 4

Evidence

8
PE
Pershing EdwardDirector, CEO
PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
Grant or award
A—Nov 26, 2025Nov 28, 2025
traded Nov 26, 2025
+2dSEC FORM 4

Evidence